ArticleScience advances2026
Multiscale insights into screw dislocation-driven growth mechanisms.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spiral growth in two-dimensional (2D) materials has conventionally been explained by single screw dislocation mechanisms, yet a complete multiscale understanding remains elusive due to the intricate nature of screw dislocation structures. Here, we present a stabilization approach through metallic transition metal dichalcogenides (m-TMDs) overlayers on spiral semiconducting TMDs (s-TMDs), which enables unprecedentedly robust atomic-resolution imaging of screw dislocations in cross-sectional van der Waals heterostructures. Our multiscale investigations identify nanoscale substrate undulations as critical nucleation sites for screw dislocations and uncover a multi-screw dislocation-driven (MSDD) growth paradigm, characterized by periodic stress stripes with linear densities approaching ∼10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.